GNMT and alcoholic fatty liver disease: Studies have reported the downregulation of GNMT in cirrhotic patients (from hepatitis C virus (HCV) and alcoholic steatohepatitis (ASH) etiologies)17 and this downregulation promotes a proinflammatory environment in the early stages of non-alcoholic steatohepatitis (NASH)18.